Opening General Session
The Future of Health and Medicine: Where Can Technology Take Us?
Daniel Kraft, M.D.
Dr. Daniel Kraft is a Stanford and Harvard trained physician-scientist, inventor and innovator who speaks on healthcare trends. He is chair of the Medicine track for Singularity University and is executive director and curator for FutureMed, a program that explores convergent, exponentially developing technologies and their potential in biomedicine and healthcare.
Kraft will deliver a provocative keynote on dramatic technological advancements affecting pharmacy education. In keeping with AACP President Lyle Bootman’s theme of “game changers,” Kraft will describe how technological changes moving rapidly toward implementation will accelerate new models of learning and patient care. Join President Bootman for an exciting kick-off to the 2013 Annual Meeting where he will highlight key accomplishments of the Association over the past year and recognize top award recipients.
Julie A. Johnson, Pharm.D., BCPS, FCCP, FAHA, V. Ravi Chandran Professor of Pharmaceutical Sciences, Distinguished Professor of Pharmacy and Medicine, University of Florida; Director, University of Florida Center for Pharmacogenomics and Director of the University of Florida Health Personalized Medicine Program
Samuel G. Johnson, Pharm.D., BCPS (AQ - Cardiology), Clinical Pharmacy Specialist - Applied Pharmacogenomics, Kaiser Permanente Colorado; Clinical Assistant Professor, University of Colorado; Institute of Medicine Anniversary Fellow in Pharmacy, 2012-14
Larisa H. Cavallari, Pharm.D., BCPS, FCCP, Associate Professor, Department of Pharmacy Practice, University of Illinois at Chicago; Co-Director of the Warfarin Pharmacogenetics Service, University of Illinois Hospital and Health Sciences System
The Science Plenary will focus on the scientific, educational and clinical perspectives for pharmacogenomics. Dr. Julie A. Johnson’s keynote will explore the horizons of genomic discovery. Dr. Samuel G. Johnson and Dr. Larisa H. Cavallari will address the clinical applications of personalized medicine at their practice sites, as well as the curricular implications for Pharm.D. programs.